Home/Filings/4/0000080424-25-000271
4//SEC Filing

Davis Jennifer L. 4

Accession 0000080424-25-000271

CIK 0000080424other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 10:22 AM ET

Size

11.9 KB

Accession

0000080424-25-000271

Insider Transaction Report

Form 4
Period: 2025-12-03
Davis Jennifer L.
CEO - Health Care
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-03$144.35/sh+60.43$8,72361,828.509 total
  • Tax Payment

    Common Stock

    2025-12-03$144.35/sh60.43$8,72361,768.079 total
  • Award

    Restricted Stock Units

    2025-11-17+33.958262.66 total
    Common Stock (33.958 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-12-0360.43965.57 total
    Common Stock (60.43 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    15,535.303
Footnotes (5)
  • [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
  • [F2]Shares withheld to cover taxes on previous Restricted Stock Unit grant.
  • [F3]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
  • [F4]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
  • [F5]Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.

Issuer

PROCTER & GAMBLE Co

CIK 0000080424

Entity typeother

Related Parties

1
  • filerCIK 0001916665

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 10:22 AM ET
Size
11.9 KB